NICE Publishes Draft Guidance Recommending the Endosure Test.
Mark Noar • July 7, 2026

The NICE published draft guidance recommending a new EndoSure test diagnostic technology. This will be for use in the NHS to speed up endometriosis diagnosis in primary care.

Endometriosis affects one in ten women of reproductive age. Endometriosis currently takes an average of more than nine years to diagnose in the UK. This new endo non-invasive test offers primary care professionals a better tool to identify the condition earlier, without relying on specialist ultrasound expertise.

The EndoSure test will be used in the NHS during a three-year evidence generation period, with NICE reviewing progress annually.

Women's health is a priority for NICE. This draft guidance builds on our updated endometriosis guideline (NG73), fertility guideline (NG257), and two recently recommended hormonal treatments for endometriosis symptoms.

Learn more about our recommendations: https://lnkd.in/d5hnS8iu

Woman taking ENDOSURE TEST for endometriosis diagnosis

ENDOSURE, INC. Announces Development of @Home Version of Award Winning ENDOSURE TEST

By Leah Hird • March 17, 2026
ENDOSURE, INC. announces development of @HOME TEST version of ENDOSURE TEST. Once released, it will make endometriosis testing possible at home.
ENDOSURE, INC.

3CPM Granted Award from National Institutes of Health RADx Tech ACT ENDO Challenge

October 7, 2025
3CPM, the company responsible for helping develop the ENDOSURE TEST, has received the midterm award in the NIH RADx Tech ACT ENDO Challenge.